Phase III randomized trial comparing neoadjuvant paclitaxel plus platinum with 5-fluorouracil plus platinum in esophageal or gastroesophageal junction squamous cell carcinoma
Authors
Oindrila Roy Chowdhury (ORCID: https://orcid.org/0000-0003-0253-9563)
Shweta Jogdhankar
Amit Janu (ORCID: https://orcid.org/0000-0002-4557-3553)
Phase III randomized trial comparing neoadjuvant paclitaxel plus platinum with 5-fluorouracil plus platinum in esophageal or gastroesophageal junction squamous cell carcinoma
Oindrila Roy Chowdhury, Shweta Jogdhankar, Amit Janu, Zoya Peelay et al.
Citations
6 citations
Journal
JNCI Journal of the National Cancer Institute
Topics
Esophageal Cancer Research and Treatment
Field-Weighted Citation Impact (FWCI)
3.44
article
Phase III randomized trial comparing neoadjuvant paclitaxel plus platinum with 5-fluorouracil plus platinum in esophageal or gastroesophageal junction squamous cell carcinoma
JNCI Journal of the National Cancer InstituteVol. 117(1)
Institutions
National Health Service (GB), University of Liverpool (GB), Homi Bhabha National Institute (IN), Tata Memorial Hospital (IN), P. D. Hinduja Hospital and Medical Research Centre (IN), Clatterbridge Cancer Centre NHS Foundation Trust (GB), Nethradhama Superspeciality Eye Hospital (IN)